Product Information
FLUVASTATIN ER 80 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $2.8793 per EA under NDC 00527258037. Its NADAC has been published 185 times since Mar 22, 2023.
FDA first approved this application on Apr 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Lannett Company Inc.NDC
00527258037
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUVASTATIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209397FDA Approved
4/26/2021
TE Code
AB
On Market Since
5/7/2021
Pharmacological Classes
Price Statistics
The NADAC for FLUVASTATIN ER 80 MG TABLET has been published 185 times since Mar 22, 2023, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8793 per EA |
|---|---|
| All-time high | $3.7076 (Jan 10, 2024) |
| All-time low | $2.3088 (May 20, 2026) |
| 52-week high | $2.8793 |
| 52-week low | $2.3088 |
| Median price | $2.7219 |
| Average price | $2.8471 |
| Largest weekly change | +45.9% (Aug 23, 2023) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluvastatin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUVASTATIN ER 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUVASTATIN ER 80 MG TABLET, manufactured by Lannett Company Inc., is $2.8793 per EA (NDC 00527258037), effective Sep 30, 2026.
How has the price of FLUVASTATIN ER 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUVASTATIN ER 80 MG TABLET has declined 17.8%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for FLUVASTATIN ER 80 MG TABLET?
Since Mar 22, 2023, the NADAC for FLUVASTATIN ER 80 MG TABLET has ranged from a low of $2.3088 (May 20, 2026) to a high of $3.7076 (Jan 10, 2024), with a median of $2.7219 per EA.
Are there cheaper alternatives to FLUVASTATIN ER 80 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVASTATIN ER 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVASTATIN ER 80 MG TABLET?
FLUVASTATIN ER 80 MG TABLET (NDC 00527258037) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.